CSF2 and neoplasm: Several genes such as Csf2, Has1, Ccl22 and Tnf induced by ruxolitinib and inhibited by IKK-16 (Fig. 5g–j) are associated with driving tumor-promoting functions in macrophages and increasing survival of tumor cells51–57.